首页> 外文会议>International Conference on Systems in Medicine and Biology >Genetic basis of HPV mediated cervical cancer in Indian women
【24h】

Genetic basis of HPV mediated cervical cancer in Indian women

机译:HPV介导宫颈癌在印度女性的遗传基础

获取原文

摘要

Cervical cancer is multi-factorial disease comprising both genetic and environmental components. Human papillomavirus is considered to be a major etiological factor for the development of cervical cancer. HPV type 16 is the most prevalent HPV accounting for more than 70% of cervical cancer cases in India, followed by HPV type 18 and other high-risk types. However, an infection with HPV is essential but it is not sufficient for the development of cervical cancer, which implies the involvement of host genetic factors. The primary cause in the development and progression of cervical neoplasia has been shown to be dependent on a series of cellular genetic and epigenetic events including mutation, deletion, polymorphism and or methylation of various tumor suppressor genes, checkpoint genes of cell cycle machinery etc. Little is known about whether genetic variation in tumor suppressor genes and cell cycle regulatory genes among Indian women associate with susceptibility to cervical cancer. We showed that promoter region of tumor suppressor genes FHIT and RASSF1A were aberrantly methylated in 28.3% and 35.0% respectively in cancer cases but both genes were methylated for 13.3% cases only. We identified a novel mutation at nucleotide position 655, at codon 98 from CAT→CGT with ultimate replacement of amino acid Histidine by Arginine in cervical cancer cases. Molecular modeling was performed to predict the effect of this mutation in disease pathology. We predict that this change, His to Arg substitution in substrate binding domain may generate catalytically inactive protein with loss of tumor suppressor activity. We also showed a novel association of cell cycle regulatory gene, cyclin D1 (CCND1) variation with cervical cancer cases in Indians. Strong evidence of CCND1G870A as risk factor and G1722C as protective factor for cervical cancer was observed. Therefore, presently studies are underway to examine the practical implications of these findings. This would give - - us important insights into genetic predisposition to cervical cancer in our population.
机译:宫颈癌是多因素疾病,包括遗传和环境组分。人乳头瘤病毒被认为是宫颈癌发育的主要病因因素。 HPV Type 16是印度宫颈癌病例的超过70%的最普遍的HPV,其次是HPV类型18和其他高风险类型。然而,具有HPV的感染是必不可少的,但对于宫颈癌的发育是不够的,这意味着宿主遗传因素的参与。宫颈瘤形成的发育和进展的主要原因已被证明依赖于一系列细胞遗传和表观遗传事件,包括各种肿瘤抑制基因的突变,缺失,多态性和或甲基化,细胞周期机械的检查点基因等众所周知,印度女性肿瘤抑制基因和细胞周期调节基因是否与宫颈癌的敏感性相关的遗传变异。我们表明,肿瘤抑制基因FHIT和RASSF1a的启动子区域分别在癌症病例中分别以28.3%和35.0%的异常甲基化,但两个基因仅为13.3%的病例。我们鉴定了核苷酸位置655的新突变,在猫→CGT的密码子98处,通过精氨酸在宫颈癌病例中通过精氨酸替代氨基酸组氨酸。进行分子建模以预测该突变在病理学中的影响。我们预测,这种变化,他在底物结合结构域中的Arg取代可以产生肿瘤抑制活性损失的催化活性蛋白质。我们还展示了一种新的细胞周期调节基因,Cyclin D1(CCND1)在印度人中宫颈癌病例的变异。观察了CCND1G870A作为危险因素和G1722C作为宫颈癌保护因子的强大证据。因此,目前正在研究正在检查这些发现的实际意义。这将使 - 美国对我们人口遗传易感性的重要见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号